Tao Bai
- Cancer Research top 1%
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 5
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 24
- Liver Disease and Transplantation 10
-
- Ferroptosis and cancer prognosis 8
- Molecular Biology top 10%
- RNA modifications and cancer 7
- Oncology top 10%
-
- Liver Disease Diagnosis and Treatment 15
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 5
- Co-authors
- Yuling SunMingxing LiZhentao QiaoYuanfeng LiuZhiwei WangRongtao ZhuRuopeng LiangFeixiang Wu
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Tao Bai
74 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Cancer Research 1.1k
- Hepatology 333
- Pulmonary and Respiratory Medicine 1.1k
- Molecular Biology 1.2k
- Oncology 279
Countries citing papers authored by Tao Bai
This map shows the geographic impact of Tao Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Bai more than expected).
Fields of papers citing papers by Tao Bai
This network shows the impact of papers produced by Tao Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Bai. The network helps show where Tao Bai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tao Bai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 10 | |
| 10 | 2023 | 4 | |
| 11 | 2021 | 0 | |
| 12 | 2021 | 3 | |
| 13 | 2021 | 15 | |
| 14 | 2021 | 2 | |
| 15 | 2020 | 42 | |
| 16 | 2017 | 119 | |
| 17 | 2016 | 1 | |
| 18 | 2013 | 35 | |
| 19 | 2012 | 31 | |
| 20 | 2009 | 4 |
About Tao Bai
Tao Bai is a scholar working on Hepatology, Cancer Research and Oncology, having authored 78 papers that have together received 2.3k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Liver Disease Diagnosis and Treatment (15 papers), Liver Disease and Transplantation (10 papers), Cancer-related molecular mechanisms research (9 papers), Ferroptosis and cancer prognosis (8 papers), RNA modifications and cancer (7 papers), MicroRNA in disease regulation (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). The work is most often cited by research in Cancer Research (1.1k citations), Hepatology (333 citations) and Pulmonary and Respiratory Medicine (1.1k citations). Tao Bai has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Yuling Sun, Mingxing Li, Zhentao Qiao, Yuanfeng Liu, Zhiwei Wang, Rongtao Zhu, Ruopeng Liang, Feixiang Wu, Weijie Wang and Lin Zhou. Their work appears in journals such as OncoTargets and Therapy, Oncology Reports, BMC Cancer, World Journal of Gastroenterology and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.